A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine whether systemic chemotherapy combined
with hepatic arterial infusion with floxuridine and dexamethasone can increase the complete
resection rate (R0) and improve the overall survival in patients with initially unresectable
colorectal liver metastasis.